Published in Br J Pharmacol on July 01, 2001
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol (2013) 5.74
Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivo. Naunyn Schmiedebergs Arch Pharmacol (2011) 1.09
Future pharmacologic agents for treatment of heart failure in children. Pediatr Cardiol (2006) 0.78
A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem (1985) 90.20
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol (1973) 47.81
pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res (1990) 12.75
Molecular cloning of the receptor for human antidiuretic hormone. Nature (1992) 2.44
Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin. Biochem Soc Trans (1979) 2.12
OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats. J Pharmacol Exp Ther (1998) 1.74
Arginine vasopressin stimulates phosphorylation of aquaporin-2 in rat renal tissue. Am J Physiol (1999) 1.50
Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol Pharmacol (1986) 1.43
Adenylate cyclase-coupled vasopressin receptor activates AQP2 promoter via a dual effect on CRE and AP1 elements. Am J Physiol (1997) 1.42
Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J Biol Chem (1994) 1.38
Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor. J Biol Chem (1994) 1.35
OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist. Science (1991) 1.34
Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors. J Clin Invest (1993) 1.28
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist. J Clin Invest (1996) 1.28
Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure. Circulation (2001) 1.27
Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist. Br J Pharmacol (1992) 1.19
Pharmacology and clinical perspectives of vasopressin antagonists. Pharmacol Rev (1991) 1.13
Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic actions: effects of highly potent analogues and competitive inhibitors. Mol Pharmacol (1978) 1.10
Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissues. Life Sci (1992) 0.95
Signal transduction of V1-vascular vasopressin receptors. Regul Pept (1992) 0.94
Pharmacological profile of YM087, a novel potent nonpeptide vasopressin V1A and V2 receptor antagonist, in vitro and in vivo. J Pharmacol Exp Ther (1997) 0.92
Direct measurement of intracellular free calcium in cultured human puerperal myometrial cells stimulated by oxytocin: effects of extracellular calcium and calcium channel blockers. Obstet Gynecol (1991) 0.87
Kinetic and pharmacological characterization of vasopressin membrane receptors from human kidney medulla: relation to adenylate cyclase activation. Eur J Pharmacol (1982) 0.87
The adenylate cyclase-coupled vasopressin V2-receptor is highly laterally mobile in membranes of LLC-PK1 renal epithelial cells at physiological temperature. EMBO J (1989) 0.86
Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs. Am J Physiol (1994) 0.86
Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cells. Br J Pharmacol (2000) 0.85
Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells. Am J Physiol (1995) 0.84
Characterization of an oxytocin-induced rise in [Ca2+]i in single human myometrium smooth muscle cells. Cell Calcium (1996) 0.83
Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.83
Characterization of the human oxytocin receptor stably expressed in 293 human embryonic kidney cells. Life Sci (1995) 0.82
Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells. Br J Pharmacol (1998) 0.81
Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 4-(1,4,5,6-tetrahydroimidazo[4,5-d][1]benzoazepine-6-carbonyl)benzanili de derivatives and 4'-(5,6-dihydro-4H-thiazolo[5,4-d][1]benzoazepine-6-carbonyl)benzanilid e derivatives. Chem Pharm Bull (Tokyo) (2000) 0.80
Highly potent and orally active non-peptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 4'-[(4,4-difluoro-5-methylidene-2,3,4,5-tetrahydro-1H-1-benzoazepin-1-y l)carbonyl]-2-phenylbenzanilide derivatives. Chem Pharm Bull (Tokyo) (2000) 0.79
Therapeutic efficacy of non-peptide ADH antagonist OPC-31260 in SIADH rats. Kidney Int (1993) 0.79
Characterization of vasopressin receptor in rat lung. Neuropeptides (1998) 0.78
Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V1A and V2 receptor antagonist, in dogs with pacing-induced congestive heart failure. Eur J Pharmacol (1999) 0.78
A rapid filtration assay for cAMP. J Biochem (1989) 0.77
Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced hyperplasia and hypertrophy of cultured vascular smooth-muscle cells. J Cardiovasc Pharmacol (1997) 0.77
Comparison of vasopressin binding sites in human uterine and vascular smooth muscle cells. Eur J Pharmacol (1999) 0.76
Cloning of the gamma chain of the human IL-2 receptor. Science (1992) 4.50
Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science (1993) 4.39
An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med (1995) 3.42
Immobilized microbial cells. Annu Rev Microbiol (1982) 2.96
Capacity of mycobacterial wax D and its subfractions to induce adjuvant arthritis in rats. Int Arch Allergy Appl Immunol (1969) 2.92
Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol (1992) 2.83
Structural analysis of cDNA for rat peroxisomal 3-ketoacyl-CoA thiolase. J Biol Chem (1987) 2.72
Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J Immunol (2001) 2.69
Maleless, a recessive autosomal mutant of Drosophila melanogaster that specifically kills male zygotes. Genetics (1975) 2.52
Complete nucleotide sequence of cDNA and predicted amino acid sequence of rat acyl-CoA oxidase. J Biol Chem (1987) 2.51
The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu Rev Immunol (1996) 2.50
The Arabidopsis dwf7/ste1 mutant is defective in the delta7 sterol C-5 desaturation step leading to brassinosteroid biosynthesis. Plant Cell (1999) 2.47
Anatomy of pharynx in patients with obstructive sleep apnea and in normal subjects. J Appl Physiol (1985) (1997) 2.44
The Arabidopsis dwarf1 mutant is defective in the conversion of 24-methylenecholesterol to campesterol in brassinosteroid biosynthesis. Plant Physiol (1999) 2.26
Replication of the resident repressed Epstein-Barr virus genome during the early S phase (S-1 period) of nonproducer Raji cells. Proc Natl Acad Sci U S A (1974) 2.18
Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res (1998) 2.15
Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J Cell Biol (2000) 2.14
Molecular cloning and nucleotide sequence of the cDNA for rat peroxisomal enoyl-CoA: hydratase-3-hydroxyacyl-CoA dehydrogenase bifunctional enzyme. J Biol Chem (1985) 2.12
Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity. J Biol Chem (1995) 2.09
Structure of Marek's disease virus DNA: detailed restriction enzyme map. J Virol (1984) 2.03
Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease. Nat Genet (2000) 2.02
The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J Cell Biol (1995) 1.99
Chlorophyll b and phycobilins in the common ancestor of cyanobacteria and chloroplasts. Nature (1999) 1.99
Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol Biol Cell (1995) 1.96
Effects of resistance exercise combined with moderate vascular occlusion on muscular function in humans. J Appl Physiol (1985) (2000) 1.94
Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood (1994) 1.94
Inhibition of macrophage migration by muramyl peptides. Infect Immun (1979) 1.91
Field test of quantum key distribution in the Tokyo QKD Network. Opt Express (2011) 1.89
Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med (1993) 1.89
Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. DNA Res (1997) 1.87
Stimulation of the reticuloendothelial system of mice by muramyl dipeptide. Infect Immun (1979) 1.84
A defect in the cytochrome b large subunit in complex II causes both superoxide anion overproduction and abnormal energy metabolism in Caenorhabditis elegans. J Biol Chem (2001) 1.84
Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res (1999) 1.82
Granuloma formation by synthetic bacterial cell wall fragment: muramyl dipeptide. Infect Immun (1978) 1.80
Wobble modification defect in tRNA disturbs codon-anticodon interaction in a mitochondrial disease. EMBO J (2001) 1.77
Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J Biol Chem (1994) 1.76
Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. DNA Res (1998) 1.74
Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J Exp Med (2000) 1.73
Apoptotic cell death of primed CD45RO+ T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis. Blood (1992) 1.72
Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem (2000) 1.72
Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils. Blood (1997) 1.71
Pharyngeal patency in response to advancement of the mandible in obese anesthetized persons. Anesthesiology (1997) 1.66
Arsenic and heavy metal contamination of vegetables grown in Samta village, Bangladesh. Sci Total Environ (2003) 1.63
FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line. J Biol Chem (1993) 1.62
Latent DNA of Epstein-Barr virus: separation from high-molecular-weight cell DNA in a neutral glycerol gradient. Proc Natl Acad Sci U S A (1974) 1.62
Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res (1999) 1.60
Altered quinone biosynthesis in the long-lived clk-1 mutants of Caenorhabditis elegans. J Biol Chem (2001) 1.59
Streptococcal sialidase. I. Isolation and properties of sialidase produced by group K Streptococcus. J Bacteriol (1967) 1.58
Ultrastructure of Candida yeasts grown on n-alkanes. Appearance of microbodies and its relationship to high catalase activity. Arch Microbiol (1974) 1.58
Immunobiologically active lipid A analogs synthesized according to a revised structural model of natural lipid A. Infect Immun (1984) 1.57
Liver transplantation using a right lobe graft from a living related donor. Transplantation (1994) 1.57
Clinical and immunological profiles of 25 patients with pemphigoid gestationis. Br J Dermatol (2014) 1.57
Detection by in situ hybridization and phenotypic characterization of cells expressing IL-6 mRNA in human stimulated blood. J Immunol (1990) 1.57
Perioperative outcomes for elective open abdominal aortic aneurysm repair since the adoption of endovascular grafting procedures. Eur J Vasc Endovasc Surg (2011) 1.56
Ultrastructure of methanol-utilizing yeast cells: appearance of microbodies in relation to high catalase activity. J Bacteriol (1975) 1.55
Adjuvant effect of cord factor, a mycobacterial lipid. Infect Immun (1976) 1.55
Rapid increase in plasma growth hormone after low-intensity resistance exercise with vascular occlusion. J Appl Physiol (1985) (2000) 1.54
Expression of desmoglein I and plakoglobin in skin carcinomas. J Cutan Pathol (2000) 1.53
Inhibition of macrophage migration by synthetic muramyl dipeptide. Biochem Biophys Res Commun (1978) 1.53
Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes (1995) 1.51
A microplate method for isolation of viruses from infants and children with acute respiratory infections. Microbiol Immunol (1987) 1.51
beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest (1993) 1.51
Lesions in the sterol delta reductase gene of Arabidopsis cause dwarfism due to a block in brassinosteroid biosynthesis. Plant J (2000) 1.50
The structure of Marek disease virus DNA: the presence of unique expansion in nonpathogenic viral DNA. Proc Natl Acad Sci U S A (1985) 1.50
Structure of the Marek's disease virus BamHI-H gene family: genes of putative importance for tumor induction. J Virol (1989) 1.50
Responder T cells depleted of alloreactive cells react to antigen presented on allogeneic macrophages from nonresponder strains. J Exp Med (1981) 1.49
Invasion of the lacrimal system by basal cell carcinoma. Dermatol Surg (1999) 1.49
Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan. J Gastroenterol (2000) 1.48
Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells. J Immunol (1983) 1.48
Identification of Epstein-Barr virus genes expressed during the early phase of virus replication and during lymphocyte immortalization. Virology (1984) 1.47
Correlation of stereochemically specific structure in muramyl dipeptide between macrophage activation and adjuvant activity. Biochem Biophys Res Commun (1977) 1.47
Visceral leishmaniasis misdiagnosed as malignant lymphoma. Intern Med (1996) 1.47
Structure of the N-linked oligosaccharides that show the complete loss of alpha-1,6-polymannose outer chain from och1, och1 mnn1, and och1 mnn1 alg3 mutants of Saccharomyces cerevisiae. J Biol Chem (1993) 1.47
In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med (1995) 1.46
Altered hepatic hemodynamics caused by temporary occlusion of the right hepatic vein: evaluation with Doppler US in 14 patients. Radiology (2001) 1.46
Vitamin C administration attenuates overload-induced skeletal muscle hypertrophy in rats. Acta Physiol (Oxf) (2013) 1.46
Regulation of B cell differentiation by T cell subsets defined with monoclonal OKT4 and OKT8 antibodies in human cord blood. J Immunol (1981) 1.46
Human cellular src gene: nucleotide sequence and derived amino acid sequence of the region coding for the carboxy-terminal two-thirds of pp60c-src. Mol Cell Biol (1985) 1.46
Clinical features of aortic arch anomaly with malalignment ventricular septal defect. Ann Thorac Surg (1989) 1.45
Cloning and functional expression of the gene encoding the key enzyme for chlorophyll b biosynthesis (CAO) from Arabidopsis thaliana. Plant J (2000) 1.45
Leucocytosis as a marker of organ damage induced by chronic strenuous physical exercise. Eur J Appl Physiol Occup Physiol (1995) 1.45
Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis. J Gastroenterol Hepatol (1996) 1.45
Transient hypertension due to adrenal hemorrhage in a patient with von Recklinghausen's disease. Intern Med (1997) 1.44
Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc Natl Acad Sci U S A (1995) 1.44
Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis. J Biol Chem (1996) 1.44
Ia antigens as restriction molecules in Ir-gene controlled T-cell proliferation. Immunol Rev (1981) 1.42
Recombinant high molecular weight-glutenin subunit-specific IgE detection is useful in identifying wheat-dependent exercise-induced anaphylaxis complementary to recombinant omega-5 gliadin-specific IgE test. Clin Exp Allergy (2012) 1.42
Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med (1992) 1.42
Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction. Biochem J (1996) 1.41
Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma. Dig Liver Dis (2006) 1.41
Motor neuron disease with dementia and ophthalmoplegia. A clinical and pathological study. J Neurol (1994) 1.41